Compare Ecopetrol SA (EC) vs Intuitive Surgical, Inc. (ISRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ecopetrol SA vs Intuitive Surgical, Inc. — how do they compare? Ecopetrol SA trades at $16.93 (market cap $34.09B), while Intuitive Surgical, Inc. trades at $415.51 (market cap $146.44B). The key difference: Intuitive Surgical, Inc. is far larger — about 4.3× Ecopetrol SA's market cap, and Ecopetrol SA pays a 3.91% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ecopetrol SA for 84 Days and Intuitive Surgical, Inc. for 84 Days on average.
| EC | ISRG | |
|---|---|---|
Market Cap | $34.09B | $146.44B |
Volume | 952,204 | 1,895,430 |
Sector | Energy | Health |
52-Week High | $18.26 | $592.85 |
52-Week Low | $8.61 | $332.02 |
Typical Hold Time | 84 Days | 84 Days |
Enterprise Value | $62.65B | $141.22B |
Dividend Yield | 3.91% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ecopetrol (EC) trades at $16.94, down 0.12% with bearish technical signals. The stock shows attractive valuation metrics including P/E of 7.99 and P/S of 0.91, but faces declining revenue from $159.6B in 2022 to $119.7B in 2025. Recent management changes and board restructuring under Colombia's new government create uncertainty, while the company maintains positive cash flow from operations despite recent earnings misses.
EC presents a value opportunity with discounted multiples but faces operational headwinds. The key investment thesis balances cheap valuation against declining revenue trends and political uncertainty. Risks include continued earnings volatility and government influence, while potential upside exists if new management can stabilize operations and reverse the revenue decline trajectory.
Intuitive Surgical (ISRG) trades at $415.41, up 2.63% with strong technical momentum and bullish moving averages. The company demonstrates robust fundamentals with 2025 revenue of $10.06B and net income of $2.86B, maintaining impressive 28.45% net margins. Recent earnings beats and expansion into new markets like India and Japan support growth despite China headwinds. Technical indicators show the stock trading near pivot point resistance at $414 with support at $411.
ISRG presents a compelling growth story with dominant robotics positioning and expanding international footprint. The 17% selloff creates opportunity with 16% upside to consensus target of $480.78. Key risks include competitive pressures in robotic surgery and procedure growth normalization. Analyst consensus remains strongly bullish with 70% buy ratings, though valuation multiples remain elevated at P/E of 47.54.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ecopetrol SA
Ecopetrol SA is a vertically integrated oil company with operations in Latin America and the United States Gulf Coast. Based out of Colombia, the company explores, develops, and conducts production activities in various countries. Ecopetrol works as the primary operator or partner in a joint venture, in a host of assets held onshore and offshore. Along with production, the company refines and markets crude oils and byproducts produced from its fields. Crude products are moved by Ecopetrol through a series of pipelines throughout Colombia, along with a network of third-party production centers and facilities.
Read more on EC →About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →
